NeuroOne Robotic Platform Drugs Brain in Experimental Procedures
NeuroOne succeeded in procedures combining robotic drug delivery with electrophysiological monitoring, validating a workflow expected to be recognized as revenue this fiscal quarte…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
NeuroOne succeeded in procedures combining robotic drug delivery with electrophysiological monitoring, validating a workflow expected to be recognized as revenue this fiscal quarte…
The company regained compliance with Nasdaq's minimum bid price requirement, citing a reverse share split. Market impact is neutral as this is a non-discretionary recovery from a p…
Dolby Laboratories announced that Marc Whitten, a veteran executive, was named President and CEO to succeed Kevin Yeaman, who is retiring after 20 years. The move comes as the audi…
Alpha Modus Holdings entered a Bitcoin-backed private placement to sell 51.6M Class A shares for ~3,170 BTC. Market participants will likely view this alternative asset collaterali…
The company agreed with KEPCO to nearly six-fold increase power capacity for its Korean operations and announced land and facility expansions to annualize 10,000 tons of magnet pro…
Glucotrack will reduce its outstanding shares to approximately 798,144 via a 1-for-15 reverse split, effective at market open on August 31, 2026. This action is necessary to regain…
DFDV resumed buying SOL, acquiring 19,000 at $98.14 average, and outperformed SOL significantly over recent periods, leading SOL digital asset company trading activity.
October's Very Own and its affiliates proposed to sell certain Intellectual Property, Overseas Merchandising, and direct sales assets and equity subsidiaries to Vinco Brands at a c…
MBX Biosciences initiated the Phase 3 oPTimize trial for once-weekly canvuparatide in hypoparathyroidism; the initiative positions the biotech firm to vie for a potential best-in-c…
Hyperliquid Strategies Inc raised $647 million, nearly doubled its HYPE treasury, and finished with a fortress balance sheet of $149.9 million cash while launching a top five valid…
The company filed a Certificate of Change to amend its certificate of incorporation, to increase the number of authorized shares of its common stock.
Parent company Abvc Pharma will distribute a 15% equity stake in BioKey (Cayman) to its shareholders, triggering a spin-off transaction.
ABVC BioPharma, Inc. announced a plan to separate BioKey (Cayman), Inc. through a spin-off and pro rata distribution of 15% of Subsidiary's ordinary shares to Parent shareholders. …
A new amendment to the company's certificate of incorporation states it will implement a 1-for-5 reverse stock split effective on August 19, 2026. This move aims to increase the ma…
The Board of White Mountains Insurance Group has elected Stephen Klar, a former president at Wellington Management Group, to its board of directors.
Scotts Miracle-Gro amended its Master Receivables Purchase Agreement to extend the termination date to August 2027. This confirms ongoing financial management and credit facilities…
Aviat Networks reported $120.9 million in Q4 fiscal 2026 revenue, a slight increase over the prior year, while maintaining a trailing book-to-bill ratio over one.
HealthEquity reported a 19% net income margin for Q2, up from 18% a year ago, while raising guidance for fiscal 2027 amid record HSA assets and stock repurchases.
The SPAC signed a definitive agreement to merge with the companies on August 27, 2026, subject to stockholder approval.
Perma-Pipe International Holdings, Inc. entered into a Credit Agreement on August 25, 2026, with JPMorgan Chase Bank, N.A. acting as the sole bookrunner and sole lead arranger.